Australian Polyclinic · Patient information
Latent TB: Tests, Contagiousness and Preventive Treatment
Reviewed and approved by Dr G Sarwar ChaudhryMBBS, FRACP (Australia), FCCP (USA) · Pulmonologist and sleep physicianClinical review:
Latent tuberculosis, also called inactive TB, means TB bacteria are present without causing active disease. People with latent TB feel well, have no TB symptoms and cannot pass TB to others. Preventive treatment can reduce the chance of the infection becoming active later.[1]
How is latent TB different from active TB?
Latent TB is infection without evidence of active illness. Active TB means the bacteria are causing disease, commonly in the lungs but sometimes elsewhere. Active lung or throat TB may spread through the air; latent infection does not. Once a clinician has confirmed that the infection is latent, isolation and separate crockery are not required simply because the test is positive.[1]
Read our separate guide to active TB, symptoms and treatment if your concern is an ongoing illness or an infectious household contact.
Who should discuss testing?
Testing is most useful when there is a meaningful risk of infection or progression to disease. Examples include close contact with infectious TB, planned medicines that suppress immunity, HIV, organ transplantation and certain other medical conditions. A clinician also considers previous TB treatment and occupational or travel exposure.[3]
After a household exposure, young children and people with weakened immunity need early assessment, even when they appear well. WHO guidance prioritizes preventive care for people most likely to benefit. Whether an infection test is required before treatment depends on age, risk and the applicable TB program; a single rule does not fit every contact.[4]
IGRA blood test or Mantoux skin test?
| Test | What to know |
|---|---|
| IGRA blood test | Measures the immune response to TB proteins. Previous BCG vaccination does not make it positive. |
| Tuberculin skin test (Mantoux) | A small injection is placed under the skin. A trained professional reads the reaction 48–72 hours later. |
A positive result suggests TB infection but cannot, by itself, distinguish latent infection from active disease. A clinical assessment and chest X-ray are usually needed; symptoms or abnormal findings may require sputum testing. A chest X-ray alone does not establish latent infection.[3]
BCG can affect a skin-test result, so an IGRA is often useful in vaccinated people. However, a positive skin test should not simply be dismissed as “just the vaccine.” The result must be interpreted with exposure history and risk.[5]
Can a test be negative after recent exposure?
Yes. The immune response takes time to become detectable. For contacts of infectious TB, a negative early blood test may need repeating 8–10 weeks after the last exposure. Immunosuppression can also affect reliability. An indeterminate or borderline result may require another test or a different approach.[6]
A negative screening result is not a reason to ignore symptoms. Tell the clinician when contact occurred and whether exposure is continuing; this helps determine when a repeat test will be meaningful.
What does preventive treatment involve?
Treatment starts only after active TB has been excluded. Common options include three months of isoniazid plus rifapentine, four months of rifampicin, or three months of isoniazid plus rifampicin. Six or nine months of isoniazid are alternatives in selected circumstances. Shorter rifamycin-based courses are often preferred when suitable.[7]
The choice depends on drug availability, age, pregnancy, liver health, other medicines and the source case’s resistance results. Exposure to drug-resistant TB requires a specialist preventive plan; ordinary regimens should not be assumed effective.[4]
Safety checks and follow-up
Rifampicin and rifapentine interact with many medicines, including hormonal contraception. Bring a complete medication list. Follow-up is generally at least monthly, with liver blood tests according to risk and symptoms. Stop the TB medicines and obtain urgent medical advice if you develop jaundice, dark urine, persistent vomiting or abdominal pain, a significant rash or other concerning adverse effects.[7]
At the first visit, ask for a written plan covering the schedule, missed doses, side effects, follow-up and whom to contact. If travel or work makes appointments difficult, raise this before treatment starts so a practical monitoring arrangement can be agreed.
Preparing for a TB consultation in Lahore
Bring the original IGRA or skin-test report, previous chest imaging, any record of TB treatment and the details of your recent exposure. If available, the source patient’s drug-resistance information can be particularly useful. Tell the clinic in advance if you currently have a cough or fever.
Dr G Sarwar Chaudhry can assess respiratory symptoms and advise on the next steps through our pulmonology service. The aim is a documented diagnosis and a clear prevention or investigation plan.
Frequently asked questions
Is latent TB contagious?
No. A person with confirmed latent TB cannot spread TB. Infectiousness becomes a concern if active lung or throat TB develops.[1]
Can I work and live normally with latent TB?
Usually yes, once active disease has been excluded. Latent TB alone does not require isolation. Follow any separate workplace assessment requirements.[1]
Does a positive IGRA mean I need full active-TB treatment?
No. It indicates infection, not which stage it is in. Clinical evaluation determines whether preventive treatment or an active-disease treatment plan is appropriate.[3]
Does BCG vaccination rule out TB infection?
No. BCG does not exclude later infection. It does not affect an IGRA result, although it can influence a skin-test result.[5]
Will my TB test become negative after treatment?
It may remain positive. Keep records of testing and completed treatment; repeating an infection test is generally not a useful way to prove cure.[3]
Can preventive treatment be used in pregnancy?
It requires an individual plan. Pregnancy affects treatment timing, medicine selection and monitoring; do not start or stop a regimen without the treating clinician.[7]
Discuss your next step
For non-emergency assessment, book with Dr G Sarwar Chaudhry at Australian Polyclinic, DHA Phase 5, Lahore. Confirm doctor availability when booking.
Sources and further reading
- CDC: About inactive tuberculosis
- CDC: Signs and symptoms of tuberculosis
- CDC: Clinical overview of latent tuberculosis infection
- WHO: Tuberculosis preventive treatment guidelines, second edition (2024)
- CDC: BCG vaccine and TB testing
- CDC: IGRA testing guidance
- CDC: Treatment for latent tuberculosis infection
Sources checked November 13, 2026.
General health information supports, but does not replace, an individual medical assessment. Seek urgent care for emergency symptoms.